Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 441,121 |
|
|||||
| News | - | ||||||
| Day High | 10.10 | Low High |
|||||
| Day Low | 9.38 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Adverum Biotechnologies Inc | ADVM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.16 | 1.70% | 9.55 | 12:27:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.60 | 9.38 | 10.10 | 9.39 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,315 | 441,121 | $ 9.51 | $ 4,192,858 | - | 7.10 - 29.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:28:00 | 1 | $ 9.57 | USD |
Adverum Biotechnologies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 964.81M | 101.03M | - | 3.6M | -117.17M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Adverum Biotechnologies News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADVM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.15 | 11.87 | 9.34 | 10.15 | 372,885 | -1.60 | -14.35% |
| 1 Month | 14.14 | 14.21 | 9.34 | 11.45 | 240,846 | -4.59 | -32.46% |
| 3 Months | 12.00 | 29.80 | 9.34 | 19.40 | 2,106,299 | -2.45 | -20.42% |
| 6 Months | 9.60 | 29.80 | 7.40 | 17.40 | 1,209,905 | -0.05 | -0.52% |
| 1 Year | 8.10 | 29.80 | 7.10 | 17.06 | 791,293 | 1.45 | 17.90% |
| 3 Years | 95.00 | 103.30 | 5.31 | 21.30 | 1,177,907 | -85.45 | -89.95% |
| 5 Years | 66.50 | 269.80 | 5.31 | 61.75 | 1,188,349 | -56.95 | -85.64% |
Adverum Biotechnologies Description
| Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single in-office intravitreal IVT injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust sustained treatment response reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor VEGF injections. |
